24. [Contingencies] Roche made an income state- ment provision of CHF 2,426 million in 1999 for costs of antitrust cases involving vitamins. Review the references to that case in Roche's financial statements.

a. How much of the 1999 provision was included in cash flows from operating activities?

b. Where does the remaining provision appear on Roche's bat- ance sheet?

c. When will the remaining provision affect cash flows from op- crating activities?

d. Discuss whether Roche shares should be valued including or excluding this provision.

e. Excluding the effect of the loss provision, should an in- vestor's view of the attractiveness of Roche shares be af- fected by this loss?